- $287.35m
- $184.79m
- $49.22m
- 49
- 24
- 81
- 50
Annual balance sheet for Cellectis SA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 268 | 186 | 97.7 | 204 | 260 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 19.2 | 31.1 | 17.6 | 23.1 | 23 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 315 | 225 | 122 | 233 | 287 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 146 | 148 | 108 | 92.7 | 75.9 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 469 | 382 | 261 | 334 | 384 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 52 | 49.3 | 48.1 | 155 | 166 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 194 | 161 | 143 | 250 | 253 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 276 | 221 | 118 | 84.7 | 131 |
| Total Liabilities & Shareholders' Equity | 469 | 382 | 261 | 334 | 384 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |